Colon cancer is a world concerning disease; it shows a high mortality rate and may be related to eating habits. Studies using inulin-like fructans, which are produced as energy supplies by several plants, have demonstrated a chemo-protective effect of these fructans in colon cancer. However, agavins a structurally different type of fructans from the Agave genus with demonstrated prebiotic effects, have been poorly studied for their possible protective effects in cancer. The aim of the present study was to evaluate the effect of Agave fructan-rich diets in colon cancer progress using a rat model and “Agave mezcalero potosino” A. salmiana Otto ex Salm Dick, which is widely distributed in Mexico. Results showed a significant decrease (p<0.05) in early lesions of colon cancer (aberrant crypt foci) compared with the control group. These data suggest that fructans from A. salmiana may contribute to a reduction in the risk of colon cancer as well as inulin-like compounds.
SanchoE. (2008) Molecular mechanisms involved in the initiation and progression of colorectal cancer. Scientific report oncology program, Barcelona: Institute for Research in Biomedicine (IRB Barcelona), pages 132–135.
2.
HijovaE., ChmelarovaA. (2007) Short chain fatty acids and colonic health. Bratislava Medical Journal, 108, 354–358.
3.
MiglioreL., MigheliF., SpisniR., CoppedèF. (2011) Genetics, cytogenetics, and epigenetics of colorectal cancer. Journal of Biomedicine and Biotechnology, Article ID792362, 19 pages. doi:10.1155/2011/792362.
4.
MacDonaldR.S., WagnerK. (2012) Influence of dietary phytochemicals and microbiota on colon cancer risk. Journal of Agricultural and Food Chemistry, 60, 6728–6735.
5.
HughesR., RowlandI.R. (2001) Stimulation of apoptosis by two prebiotics Chichorium fructans in the rat colon. Carcinogenesis, 22, 43–47.
6.
KaurN., GuptaA.K. (2002) Applications of inulin and oligofructose in health and nutrition. Journal of Biosciences, 27, 703–714
7.
ReddyB.S. (1999) Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. Journal of Nutrition, 129, 1478S–1482S
RoyC.C., KienC.L., BouthillierL., LevyE. (2006) Short-chain fatty acids: ready for prime time?Nutrition in Clinical Practice, 21, 351–366.
11.
CananiR.B., Di CostanzoM., LeoneL., PedataM., MeliR., CalignanoA. (2011) Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology, 17, 1519–1528
12.
ScharlauD., BorowickiA., HabermannN., HofmannT., KlenowS., MieneC., MunjalU., SteinK., GleiM. (2009) Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fiber. Mutation Research, 682, 39–53.
13.
ScheppachW., WeilerF. (2004) The butyrate story: old wine in new bottles?Current Opinion in Clinical Nutrition and Metabolic Care, 7, 563–567.
14.
Pool-ZobelB.L. (2005) Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. British Journal of Nutrition, 93, S73–S90.
15.
LeonelA.J., Alvarez-LeiteJ.I. (2012) Butyrate: implications for intestinal function. Current Opinion in Clinical Nutrition and Metabolic Care, 15(5), 474–479. doi: 10.1097/MCO.0b013e32835665fa.
16.
BonnettG.D., SimsI.M., St JohnJ.A., SimpsonR.J. (1994) Purification and characterization of fructans with β-2, 1- and β-2, 6-glycosidic linkages suitable for enzyme studies. New Phytologist, 127, 261–269.
17.
SimsI.M. (2003) Structural diversity of fructans from members of the order Asparagales in New Zealand. Phytochemistry, 63, 351–359.
18.
LópezM.G., Urías SilvasJ.E. (2007) Agave fructans as prebiotics, Recent Advances in Fructo-oligosaccharides Research. Norio S, Noureddine B, Shuichi O. (Eds) ISBN: 81–308-0146–9.
19.
Huazano-GarcíaA., LópezM.G. (2013) Metabolism of short chain fatty acids in the colon and faeces of mice after a supplementation of diets with Agave fructans in lipid metabolism, Valenzuela BaezR. (Ed), ISBN: 978–953–51-0944-0, In Tech, DOI: 10.5772/51248.
20.
Aguirre RiveraJ.R., CharcasH., FloresJ.L. (2001) El Agave mezcalero potosino. Universidad Autónoma de San Luis Potosí y Consejo Potosino de Ciencia y Tecnología (Ed). San Luis Potosí S. L. P., México. 87 pages.
21.
LeónM.V., Roque SáenzF. (2007) Focos de criptas aberrantes, el comienzo de la historia. Gastroenterología Latinoamericana, 18, 383–389.
22.
LópezM.G., Mancilla-MargalliN.A., Mendoza-DíazG. (2003) Molecular structures of fructans from Agave tequilana Weber var. azul. Journal of Agricultural and Food Chemistry, 51, 7835–7840.
23.
ProphetE. (1992) Laboratory Methods in Histotechnology.Armed Forces Institute of Pathology, Washington D.C., USA.57–58.
24.
SAS (1999) User's Guide: Statistics [CD-ROM Computer file]. Version 8. SAS Inst. Inc.Cary, NC USA.
25.
RoberfroidM., GibsonG.R., HoylesL., McCartneyA.L., RastallR., RowlandI., WolversD., WatzlB., SzajewskaH., StahlB., GuarnerF., RespondekF., WhelanK., CoxamV., DaviccoM.J., LéotoingL., WittrantY., DelzenneN.M., CaniP.D., NeyrinckA.M., MeheustA. (2010) Prebiotic effects: metabolic and health benefits. British Journal of Nutrition, 104(S2), S1–S63doi: 10.1017/S0007114510003363.
26.
Rendón-HuertaJ.A., Juárez-FloresB.I., Pinos-RodríguezJ.M., Aguirre-RiveraJ.R., Delgado-PortalesR.E. (2011) Effects of different sources of fructans on body weight, blood metabolites and fecal bacteria in normal and obese non-diabetic and diabetic rats. Plant Foods for Human Nutrition, 67, 64–70.
27.
D'ArgenioG., MazzaccaG. (1999) Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Advances in Experimental Medicine and Biology, 472, 149–158.
28.
JiangT., SavaianoD.A. (1997) Modification of colonic fermentation by bifidobacteria and pH in vitro impact on lactose metabolism, short-chain fatty acid, and lactate production. Digestive Diseases and Sciences, 42, 2370–2377.
29.
PanX., ChenF., WuT., ZhaoZ. (2009) Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel. Journal of Zhejiang University, 10, 258–263.
30.
PerrinP., PierreF., PatryY., ChampM., BerreurM., PradalG., BornetF., MeflahK., MenanteauJ. (2001) Only fibers promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats. Gut, 48, 53–61.
31.
McIntyreA., GibsonP.R., YoungG.P. (1993) Butyrate production from dietary fiber and protection against large bowel cancer in a rat model. Gut, 34, 386–91.
32.
NordgaardI., HoveH., ClausenM.R., MortensenP.B. (1996) Colonic production of butyrate in patients with previous colonic cancer during long-term treatment with dietary fibre (Planta goovata seeds). Scandinavian Journal of Gastroenterology, 31, 1011–1020
33.
BertkovaI., HijovaE., MojzisovaG., PetrasovaD., StrojnyL., BombaA., ZitnanR. (2010) The effect of probiotic microorganisms and bioactive compounds on chemically induced carcinogenesis in rats. Neoplasma, 57, 422–428.
34.
Pool-ZobelB.L., Van LooJ., RowlandI., RoberfroidM.B. (2002) Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. British Journal of Nutrition, 87, 273–281.
